Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Dogs Horses Veterinary Applications: Research Comparison

Equine tendon injury Promotes cell migration into lesion, increases angiogenesis, reduces inflammatory cytokine persistence 10mg SC twice weekly × 4 weeks, then 10mg weekly × 8–12 weeks Moderate. Controlled studies show faster wound closure and vascularisation

This comparison does not assign a generated winner or score.

  • Equine tendon injury
  • Promotes cell migration into lesion, increases angiogenesis, reduces inflammatory cytokine persistence
  • 10mg SC twice weekly × 4 weeks, then 10mg weekly × 8–12 weeks
  • Moderate. Controlled studies show faster wound closure and vascularisation, but tensile strength improvement is inconsistent
  • Most promising application. Ultrasound follow-up essential to confirm structural healing matches clinical improvement
  • Canine surgical wound healing
  • Accelerates keratinocyte migration, increases collagen deposition, reduces hypertrophic scar formation
  • 2.5mg SC twice weekly × 4 weeks post-surgery
  • Moderate. Small studies (n=20–40) show 30–40% faster epithelialisation vs controls
  • Useful adjunct in high-risk surgical cases (e.g., large skin grafts, contaminated wounds). Not necessary for routine surgeries
  • Equine joint inflammation (osteoarthritis)
  • Modulates synovial cytokine environment, may reduce cartilage degradation markers
  • 10mg IM weekly × 12 weeks, often combined with hyaluronic acid or corticosteroids
  • Low. Anecdotal reports common, but controlled trials show minimal effect on lameness scores or radiographic progression
  • Weak evidence. Hyaluronic acid alone produces similar outcomes at lower cost
  • Canine cruciate ligament repair recovery
  • Enhances ligament-bone interface healing, reduces post-surgical adhesion formation
  • 2.5mg SC twice weekly × 6 weeks post-TPLO or TTA surgery
  • Low-moderate. Retrospective case series suggest faster return to function, but no blinded RCTs exist
  • Plausible mechanism, but current evidence doesn't justify routine use. Consider in competitive/working dogs where faster recovery has significant value
  • Equine corneal ulcer healing
  • Promotes corneal epithelial migration, increases tear film stability
  • 5mg subconjunctival injection weekly × 3 weeks
  • Low. Case reports only, no comparative trials
  • Mechanistically sound, but subconjunctival injection carries risk. Standard topical therapy (autologous serum, atropine) remains first-line
More references

Related material